According to a Jan. 4 news release from Elevance Health, the company will operate as part of CarelonRx, the pharmacy services segment in Carelon, Elevance’s healthcare services arm.
Plano, Texas-based Paragon Healthcare has more than 40 ambulatory infusion centers in eight states, serving more than 35,000 patients on-site and in their homes. In the news release, Elevance said it will expand Paragon’s geographic footprint after the acquisition.
“Together, Elevance Health and Paragon Healthcare will have the ability to provide members with greater choice on the most appropriate site of care options, such as ambulatory or in-home locations, which will remove barriers to care and better support members’ whole health,” Pete Haytaian, executive vice president of Elevance Health and president of Carelon, said.
The deal is expected to close in the first half of 2024, Elevance said.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.